Molecular Neurobiology

Molecular Neurobiology is a bimonthly journal established in 1987 and published by Springer, covering all aspects of molecular neuroscience, with a 2025 Journal Impact Factor of 5.5.《分子神经生物学》（Molecular Neurobiology）为双月刊，1987 年创办，由（Springer）出版，覆盖分子神经科学的各个方面，2025 年影响因子为 5.5。

Scope

• The journal covers all aspects of molecular neuroscience and contemporary molecular brain research.本刊覆盖分子神经科学与当代分子脑研究的各个方面。
• Neurodegenerative disease mechanisms, including protein aggregation, are major subjects.神经退行性疾病的机制，包括蛋白质聚集，是主要主题。
• Neurodevelopment, neural stem cells and the molecular control of circuit formation are published.神经发育、神经干细胞以及神经环路形成的分子调控均予发表。
• Synaptic plasticity, learning and memory at the molecular level are covered.分子层面的突触可塑性、学习与记忆均有收录。
• Neuronal signalling pathways, receptors, channels and second messengers are treated at length.神经元信号通路、受体、离子通道与第二信使受到重点讨论。
• Neuroinflammation and the molecular crosstalk between glia and neurons are within scope.神经炎症以及胶质细胞与神经元之间的分子互作均在其范围之内。
• Molecular genetics and epigenetics of neurological and psychiatric disorders are represented.神经与精神疾病的分子遗传学与表观遗传学均有收录。

History

• Molecular Neurobiology was established in 1987 to provide a dedicated forum for molecular brain research.《分子神经生物学》创办于 1987 年，为分子脑研究提供专门的园地。
• It was published originally by Humana Press of Totowa, New Jersey, and became part of Springer.本刊最初由新泽西州托托瓦的（Humana Press）出版，其后并入（Springer）。
• The journal is issued every two months and publishes original research as well as reviews.本刊每两个月出版一期，发表原创研究与综述。
• Benedict C. Albensi was appointed editor-in-chief in early 2020, taking over the journal's direction.Benedict C. Albensi 于 2020 年初获任主编，接手期刊的办刊方向。
• Its impact factor stood at 5.590 in 2020 and 5.5 in 2025, and the title remains in the first quartile of neurosciences.其影响因子在 2020 年为 5.590，2025 年为 5.5，本刊稳居神经科学类第一分区。
• The journal is indexed in the Science Citation Index, Scopus, MEDLINE/PubMed and BIOSIS Previews.本刊被（Science Citation Index）、（Scopus）、（MEDLINE）、（PubMed）与（BIOSIS Previews）收录。

Editors

• Benedict C. Albensi, a neuroscientist working on memory and neuroinflammation, serves as editor-in-chief.从事记忆与神经炎症研究的神经科学家 Benedict C. Albensi 担任主编。
• He is supported by associate editors covering neurodegeneration, development, synaptic physiology and neuropharmacology.协助他的副编辑覆盖神经退行、发育、突触生理与神经药理学等方向。
• The board is international, and the journal deliberately synthesises trends for graduate students and postdoctoral researchers as well as for established scientists.编委会具有国际性，本刊有意为研究生与博士后以及资深科学家梳理研究趋势。
• Manuscripts are peer reviewed, and the journal publishes original research and review articles.稿件经同行评审，本刊发表原创研究与综述。
• The journal operates a hybrid model, so authors may publish open access on payment of a charge.本刊采用混合模式，作者可付费选择开放获取发表。
• Special issues gather work on single themes such as neuroinflammation or molecular psychiatry.专刊围绕神经炎症、分子精神病学等单一主题汇集论文。